Northwest Territories Join Canadian Biosimilar Switching Charge

Five Canadian Jurisdictions Now Have Biosimilar Switching Policies

The Canadian Northwest Territories have become the fifth jurisdiction and first territorial government to implement a biosimilar switching policy.

Northwest Territories flag
Biologics make up some of the largest drug costs incurred by the Government of the Northwest Territories • Source: Alamy

The Canadian Northwest Territories have become the fifth jurisdiction to roll out a biosimilar switching policy in the country, following in the footsteps of British Columbia, Alberta, Quebec and New Brunswick.

Known as the Biosimilars Initiative, the policy will generate savings “to be reinvested to help fund coverage by increasing the...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.